| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 09/01/2004 | EP1242410B1 Novel compounds |
| 09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP0764172B1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525865A Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525849A Olopatadine formulations for topical administration |
| 09/01/2004 | CN1524571A A medicament and its preparation process |
| 09/01/2004 | CN1524562A Caspule for treating cough |
| 09/01/2004 | CN1524561A Capsule for curing faucitis |
| 09/01/2004 | CN1524542A Medicament for treating acute and chronic rhinitis and nasosinusitis |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1164599C Process for preparing total alkaloid of siberian fritillary bulb with antitussive and phlegm-eliminating action |
| 09/01/2004 | CN1164332C Preparation method of horse SARS-resisting serum |
| 09/01/2004 | CN1164325C Antiphlogistic capsule capable of keeping the adverse energy downwards |
| 09/01/2004 | CN1164320C Medicament for treating bronchial disease |
| 09/01/2004 | CN1164319C Medicament for treating epistaxis |
| 09/01/2004 | CN1164315C Medicine for treating throat disease |
| 09/01/2004 | CN1164312C Solid antitussive ointment and preparation method thereof |
| 09/01/2004 | CN1164305C Medicinal powder for curing laryngopharyngitis and ulcerations of the oral cavity |
| 09/01/2004 | CN1164298C Chinese medicine for treating cold and cough and its preparation method |
| 09/01/2004 | CN1164295C Application of agave |
| 09/01/2004 | CN1164283C Pneumonia treating Chinese medicine powder |
| 09/01/2004 | CN1164267C Medical use of Chlorogenic acid and formulation thereof |
| 09/01/2004 | CN1164263C Ambroxol-containing suctorial type tablet |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784156 Cyclosporins for the treatment of respiratory diseases |
| 08/26/2004 | WO2004072272A1 Bacterial compositions |
| 08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
| 08/26/2004 | WO2004072037A1 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 08/26/2004 | WO2004071573A2 Hypoxia induced mitogenic factor |
| 08/26/2004 | WO2004071522A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 08/26/2004 | WO2004071395A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 08/26/2004 | WO2004071392A2 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 08/26/2004 | WO2004071388A2 Medicinal compounds |
| 08/26/2004 | WO2004071384A2 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 08/26/2004 | WO2004071383A2 New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action |
| 08/26/2004 | WO2004071381A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 08/26/2004 | WO2004071378A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167174 Substituted acylhydroxamic acids and method of reducing TNFalpha levels |
| 08/26/2004 | US20040167162 therapy for infection of adenovirus, rhinovirus ; using an (amino or hydroxy)quinoline compound |
| 08/26/2004 | US20040167155 Treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, diabetes and autoimmune diseases |
| 08/26/2004 | US20040167154 Urea substituted imidazoquinolines |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040167099 Mucoadhesive tetracycline formulations |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | US20040166114 Remedies for interstitial pneumonia, method of preparing animal model of said disease, and screening method using the same |
| 08/26/2004 | US20040166113 Administering interleukin inhibitor |
| 08/26/2004 | US20040166112 Administering interleukin inhibitors |
| 08/26/2004 | DE10306202A1 2-(hetero)aryl-2-(N-((hetero)aryl)-amino)-acetic acid derivatives useful e.g. for treating anxiety, inflammation, allergy, depression, diarrhea or especially pain is NMDA antagonist |
| 08/26/2004 | CA2515534A1 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 08/26/2004 | CA2515530A1 New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action |
| 08/26/2004 | CA2515395A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1449528A1 Treatment of respiratory diseases |
| 08/25/2004 | EP1448986A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 08/25/2004 | EP1448790A2 Methods and compositions for treating cancer |
| 08/25/2004 | EP1448583A2 A novel g protein-coupled receptor, gave8 |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448562A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 08/25/2004 | EP1448552A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448545A1 Nf-kb inhibitors |
| 08/25/2004 | EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448531A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/25/2004 | EP1448529A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 08/25/2004 | EP1448528A2 Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448205A2 Combinations for the treatment of immunoinflammatory disorders |